Search

2024 JUN 29 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on Nanotechnology - Nanomicelles is now available. According to [...]

2023 SEP 30 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in Nanotechnology - Nanomicelles. According to news reporting [...]

Children often present unique yet rewarding challenges when it comes to prescribing medications for ocular pathology. Drugs that are used in adults may sometimes be contraindicated in children or not [...]

In recent years, management of glaucoma has changed considerably, adding an enhanced prostaglandin analog, an entirely new class of drugs and a new sustained-release delivery system. The discussion with patients [...]

It triggers--and perpetuates--this all-too-common condition. Here's a look at the therapies available to fight it. The prevalence of dry eye disease (DED) is rising around the world and with that [...]

Q Is it still best to use non-generic Pred Forte to treat iritis? I had a pharmacist who recently changed my prescription to a generic and they said it was [...]

The definition of glaucoma is changing rapidly as our understanding of the pathogenesis of damage to the retina and optic nerve improves. However, the disease can still be described generally [...]

Unsurprisingly, there was keen interest in the treatment of COVID-19 viral conjunctivitis. Let us not lose perspective that most all ocular infections are indeed adenoviral, and the literature tells us [...]

2022 MAR 19 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in antibiotics. According to news reporting from Shanghai, [...]

Byline: Anil. Gangwe, Deepanshu. Agrawal, Anand. Vinekar, Raj. Azad, Swapnil. Parchand, Deepshikha. Agrawal Purpose: To report the results of the survey for the role of anti-VEGF in the management of [...]

INTRODUCTION Identification and management of dry eye disease (DED) is evolving with the development of new diagnostic tools and therapeutic modalities. At the same time, ophthalmologists are becoming more aware [...]

Byline: Hrishabh. Jaiswal, Narendra. Patidar, Chintan. Shah, Rukmendra. Singh, Elesh. Jain, Parimal. Piyush Purpose: To study topical timolol (0.5%) as a first-line treatment in ophthalmic pyogenic granuloma (PG) in terms [...]

Byline: Aman. Kumar, Divya. Agarwal, Atul. Kumar Anti-vascular endothelial growth factor (anti-VEGF) agents including Bevacizumab, Ranibizumab, Aflibercept, and the latest molecule Brolucizumab have caused a paradigm shift in the management [...]

The use of minimally invasive glaucoma surgeries (MIGS) has increased markedly over the previous 6 years in the United States, with a concomitant (albeit smaller) decrease in traditional trabeculectomies and [...]

Q List the blood product options for dry eye patients. What are their advantages and disadvantages? What contraindications and risks do they carry? A Dry eye disease is an increasingly [...]

Optometry dominates in ophthalmic drug prescribing, as is evident by the fact that only 18% of prescriptions for Vuity (pilocarpine 1.25%, Allergan)--the new presbyopia eye drop--have come from ophthalmologists. It's [...]

We have a robust selection of therapies that allows us to treat the root cause of most signs and symptoms of dry eye disease. However, despite the countless innovations, most [...]

For astronauts on long spaceflights, prolonged exposure to microgravity can result in symptoms of spaceflight-associated neuro-ocular syndrome (SANS), including optic disk edema, globe flattening, and retinal folds. Astronauts also commonly [...]

Treating dry eye has become a significant part of practicing optometry, and many of us are seeing a growth in this part of our practices. Patient complaints of eyes that [...]

Suppose you have a patient with herpes simplex keratitis who experiences severe corneal toxicity secondary to Viroptic (trifluridine 1%, Glaxo-SmithKline) or who requires antiviral coverage during the night. Traditionally, we [...]

New ocular pharmacologic agents or new uses for familiar products are discovered every year. This article discusses a select few of these newer therapies in veterinary ophthalmology. For convenience, the [...]

With energy prices soaring, most people hear the word "pipeline" and immediately think of oil. But in health care, the word describes a vital flow of new medications and technologies [...]

This class of ophthalmic drugs is highly useful and rivals the pure topical corticosteroids in the treatment of the acute red eye. As with most drugs, there are clear indications [...]

What do you do with your drug samples? Do you give them away like candy so they're gone a few days after you receive them? Or, do you stock them [...]

A 35-year old Hispanic male presented with painless, progressive vision loss O.D. over three months. He also reported the onset of floaters without photopsia. An ophthalmologist examined him three weeks [...]

KAYSERI, TURKEY :: A NEW MATRIX THERAPY AGENT (CACICOL20) may provide faster corneal healing after epithelial-off crosslinking with ultraviolet A and riboflavin, said Koray Gumus, MD. Corneal crosslinking (CXL) has [...]

Horner's syndrome is a neurologic condition resulting from paralysis of the cervical sympathetic nerve trunk. Symptoms include pupil contraction, blepharoptosis (drooping of the upper eyelid), and anhidrosis (inadequate facial perspiration). Since 1971, diagnosis of Horner's syndrome has been made by instillation of cocaine to detect paralysis of the sympathetic system, followed by hydroxyamphetamine eyedrops, which identifies the site of the lesion. Although the cocaine test may be omitted when the diagnosis is certain, there is no other method of accurately identifying the site of the lesion other than using hydroxyamphetamine eyedrops. Production of this drug (known as Paredrine) was discontinued by the manufacturer (Smith, Kline Beecham) in 1987. Because Paredrine is an amphetamine, it was banned from some countries in the 1970's to avoid its use as a recreational drug. However, its chemical structure is sufficiently different from recreational amphetamines so that it does not create central euphoric effects. Hydroxyamphetamine has full Food and Drug Administration approval for ophthalmologic use, and only needs a manufacturer to produce and sell it. Many ophthalmologists and neuro-ophthalmologists would be pleased if this drug were again available. (Consumer Summary produced by Reliance Medical Information, Inc.)

THE CASE A 35-year-old foreman presented with a painful right eye. He admitted the eye was sensitive to light but denied any discharge. He always wore goggles at work to [...]

Michael E Johnson describes the actions of this common antibacterial agent and the implications for eye care practitioners of the new legislative changes. CET Module C2284 Earlier this year the [...]

Botulinum toxin chemodenervation has evolved greatly over the past 30 years since its introduction in the 1970s for the management of strabismus. Among ophthalmic plastic surgeons, botulinum toxins are often [...]

Byline: Liao, Sharon Gray hair. Taxes. Thick-as-bricks eyeglasses. Which of these seemingly inevitable bullets can you successfully dodge? Experts believe it could be the specs. New research suggests that even [...]

Professor John Lawrenson outlines general pharmacological principles and specifically describes the factors involved in the absorption, distribution and metabolism of ophthalmic drugs (C4823j) The science of pharmacology is concerned with [...]

For the past 25 years, the medical management of glaucoma has become increasingly successful. The medications currently available have superior tolerability and efficacy compared with the most commonly used drugs [...]

In the first of two articles concerning pupil dilation, Dr John Siderov describes the pharmacological considerations and the clinical indications for dilating patients in optometric practice Pupillary dilation through the [...]

Ultralase has claimed a high level of accuracy from its wavefront-guided laser eye procedures. Speaking at London's Royal College of Physicians, consultant ophthalmic surgeon Joseph Karthikappallil revealed that the Leeds-based [...]

Data compiled by NDC Health indicate that U.S. ophthalmic beta-blocker sales currently exceed $170 million per year, with more than 4.4 million prescriptions written annually. Clinicians will soon be able [...]